An open label, balanced, randomized, two-treatment, two-period, two-sequence, single dose, crossover oral bioequivalence study of Dapagliflozin Tablets 10 mg in healthy adult human subjects under fasted conditions

Authors
Category Primary study
Registry of TrialsThai Clinical Trials Registry
Year 2024
This article has no abstract
Epistemonikos ID: 0cc5eb5fea7c85f2b19ef0a82c71cb5324ef8077
First added on: Apr 11, 2025